PATENT CLAIM ANALYSIS

Application Number: 16109127
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "020500"]

Abstract:
The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.

Claim (Index 44):
The kit according to  claim 43 , wherein the ratio of the volume of the pharmaceutical composition in the container to the total volume of the container is between 0.4 to 0.7, or wherein the ratio of the volume of the head space of the container to the volume of the pharmaceutical composition is between 0.5 to 1.5.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15142709', '15676968', '12685510', '13601258', '15742867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7681829660823933
- 35 USC 102 Novelty (BERT): 0.522546847225585
- Combined Prediction Score: 0.7436193541967124
- Mean Citation Score: 251.82278
- Max Citation Score: 280.8045
- Similarity Product: 157.87851911956076

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test